IYRC Journal
  • Information
    • Editorial Board
    • Reviewer Board
  • Articles
    • 2026 - 1st Issue
    • 2025 - 2nd Issue
    • 2025 - 1st Issue
    • 2024
  • Guide for authors
  • SUBMISSION
    • Submission system
  • Become a reviewer

The Effectiveness of Mesenchymal Stem Cells as a Treatment for Osteogenesis Imperfecta: A Systematic Review

Lexie Wu
Hunter College High School, New York City, U.S.
​​​​Publication date: July 19, 2026
​DOI: http://doi.org/10.34614/JIYRC2026I44
ABSTRACT 
Osteogenesis imperfecta (OI) is a heritable genetic disease that affects type I collagen production, causing bones to be brittle and vulnerable to fracture. Current treatments that aim to reduce fracture rate are varyingly successful. Administration of mesenchymal stem cells (MSCs) could be a more effective treatment for OI because of their ability to differentiate and migrate. A systematic literature review was performed following the PRISMA guidelines based on published studies involving the administration of MSCs in oim mouse models as well as human patients by exploring and evaluating how they work and their effectiveness and practicality in increasing bones’ mechanical strength. Bone affected by OI treated with MSCs result in reduced fracture rates, increased bone mineral content, increased osteogenesis rates, and increased mechanical strength.

PAPER
Download PDF
Picture
THE INTERNATIONAL YOUNG
RESEARCHERS' CONFERENCE



一般社団法人 IYRC
   〒106-0032 東京都港区六本木7丁目2番28-605号
    電話番号: 03-3527-9323

    GET IN TOUCH

Submit
  • Information
    • Editorial Board
    • Reviewer Board
  • Articles
    • 2026 - 1st Issue
    • 2025 - 2nd Issue
    • 2025 - 1st Issue
    • 2024
  • Guide for authors
  • SUBMISSION
    • Submission system
  • Become a reviewer